Top Research From SABCS 2025
Update: 2025-12-15
Description
The 2025 San Antonio Breast Cancer Symposium featured four days filled with new research findings, poster presentations, and educational sessions. Marisa Weiss, MD, founder and chief medical officer of Breastcancer.org, offers her take on the top results.
Listen to the episode to hear Dr. Weiss explain:
- how giredestrant, a new oral SERD for early-stage, hormone receptor-positive breast cancer, may change practice
- a new use for Tukysa (chemical name: tucatinib) in metastatic HER2-positive disease
- the lifestyle factors that can affect breast cancer risk and steps people can take to keep their risk as low as possible
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
